Cancer Anorexia
Cancer Anorexia is a condition where individuals with cancer experience a significant loss of appetite, leading to weight loss and nutritional deficiencies. This can be caused by the cancer itself or its treatments.
We are testing a new synthetic cannabinoid to see if it helps patients with cancer gain weight and improve appetite. The study also looks at the safety and quality of life for participants.
Health conditions and diseases that the clinical trial is designed to study and treat.
Cancer Anorexia is a condition where individuals with cancer experience a significant loss of appetite, leading to weight loss and nutritional deficiencies. This can be caused by the cancer itself or its treatments.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.